These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2911035)

  • 1. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase by N-methylisoquinolinium ion.
    Naoi M; Hirata Y; Nagatsu T
    J Neurochem; 1987 Mar; 48(3):709-12. PubMed ID: 3806102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions.
    Naoi M; Maruyama W; Sasuga S; Deng Y; Dostert P; Ohta S; Takahashi T
    Neurochem Int; 1994 Nov; 25(5):475-81. PubMed ID: 7849576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion.
    Naoi M; Matsuura S; Takahashi T; Nagatsu T
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1213-9. PubMed ID: 2742585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.
    Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M
    Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of mitochondrial and synaptosomal monoamine oxidase in monkey brain.
    Egashira T; Yamamoto T; Yamanaka Y
    Jpn J Pharmacol; 1984 Feb; 34(2):211-9. PubMed ID: 6431160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships.
    Thull U; Kneubühler S; Gaillard P; Carrupt PA; Testa B; Altomare C; Carotti A; Jenner P; McNaught KS
    Biochem Pharmacol; 1995 Sep; 50(6):869-77. PubMed ID: 7575650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products.
    Youngster SK; McKeown KA; Jin YZ; Ramsay RR; Heikkila RE; Singer TP
    J Neurochem; 1989 Dec; 53(6):1837-42. PubMed ID: 2809594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrate.
    Reyes-Parada M; Scorza MC; Silveira R; Dajas F; Cassels BK
    Life Sci; 1994; 54(25):1955-63. PubMed ID: 8201844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine, a 1-amino analog of MPTP, by type A and B monoamine oxidase.
    Umeda M; Aoyama S; Kaiya T; Kohda K; Maruyama W; Naoi M
    J Neural Transm (Vienna); 1998; 105(10-12):1253-64. PubMed ID: 9928894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography.
    Naoi M; Takahashi T; Nagatsu T
    Anal Biochem; 1987 May; 162(2):540-5. PubMed ID: 3496809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
    Rao KS; Rao GV
    Mol Cell Biochem; 1994 Aug; 137(1):57-60. PubMed ID: 7845378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some interrelated properties of A and B form monoamine oxidase in monkey brain mitochondria.
    Egashira T; Yamamoto T; Yamanaka Y
    Jpn J Pharmacol; 1984 Mar; 34(3):327-34. PubMed ID: 6427500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.